abstract |
The present invention relates to pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formulawherein X, Y, Ar1, Z, R1, R2 and R3 are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders. |